Human miR‐1228 as a stable endogenous control for the quantification of circulating microRNAs in cancer patients
Jie Hu(Zhongshan Hospital), Jiping Wang(CAE (Canada)), Jian Zhou(Shenzhen University Health Science Center), Xin Zhang(Fudan University), Boyi Liao(Ministry of Education of the People's Republic of China), Qing Chen(Zhongshan Hospital), Jia Fan(Nanjing Tech University), Ying Wu(Zhejiang Chinese Medical University), Xue Gao(Emory University), Shuyang Wang(Sun Yat-sen University), Shaohua Lu(Sun Yat-sen University), Zheng Wang(Fudan University), Hongguang Zhu(Qingdao University), Lei Yu(Taiyuan Central Hospital), Shuang‐Jian Qiu(Fudan University), Zhi Dai(Ministry of Education of the People's Republic of China)
Cited by 102
Related Papers
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
|Nature|2019|982
Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)
|Liver Cancer|2020|828
Plasma MicroRNA Panel to Diagnose Hepatitis B Virus–Related Hepatocellular Carcinoma
|Journal of Clinical Oncology|2011|644